Vertex One Asset Management’s Aralez Pharmaceuticals Inc. ARLZ Stock Holding History

Vertex One Asset Management’s Portfolio ARLZ Stock Details ARLZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-323,613	Closed	-$1.57M	–	140
2016 Q3	$1.57M	Sell	323,613 -100,000	-24%	-$456K	0.25%	74
2016 Q2	$1.4M	Hold	423,613	–	–	0.23%	72
2016 Q1	$1.5M	Buy	+423,613	New	+$2.18M	0.22%	71

Other funds holding ARLZ

PCM

PAR Capital Management Boston, Massachusetts $4.03B AUM 35.05% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

JAM

JW Asset Management Miami Beach, Florida $320M AUM 140.1% 1-Year Est. Return

ECP

Elk Creek Partners Denver, Colorado $582M AUM 10.23% 1-Year Est. Return

TLCM

Tiger Legatus Capital Management New York $62.4M AUM 24.33% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

HVC

Healthcare Value Capital Woodcliff Lake, New Jersey $50.7M AUM 24.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vertex One Asset Management's ARLZ Position: Q4 2016 in Review

Vertex One Asset Management sold out of Aralez Pharmaceuticals Inc. (ARLZ) in Q4 2016, closing a stake of 323,613 shares — an estimated $1.57M sold.

Vertex One Asset Management first reported a position in ARLZ in Q1 2016 and held it in 3 quarters. The position peaked at $1.57M in Q3 2016. 83 funds tracked by Wall St. Rank hold ARLZ as of Q4 2016.

Vertex One Asset Management reported no remaining Aralez Pharmaceuticals Inc. position as of Q4 2016 after selling out during the quarter.
Vertex One Asset Management sold 323,613 Aralez Pharmaceuticals Inc. shares in Q4 2016, an estimated $1.57M.
Vertex One Asset Management first reported a position in Aralez Pharmaceuticals Inc. in Q1 2016 and held it in 3 quarters.
Vertex One Asset Management's Aralez Pharmaceuticals Inc. position peaked at $1.57M in Q3 2016.
83 funds tracked by Wall St. Rank held Aralez Pharmaceuticals Inc. as of Q4 2016.

Based on Vertex One Asset Management's 13F filing for Q4 2016, filed 14 Feb 2017.